meglitinide has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, SN; Lamos, EL; Stein, SA | 1 |
| Kashyap, SR; Kattan, MW; Raghavan, D; Sun, GE; Wells, BJ; Yip, K; Zimmerman, R | 1 |
| Berlin, JA; Demissie, K; Marcella, SW; Qiu, H; Rhoads, GG | 1 |
1 review(s) available for meglitinide and Neoplasms
| Article | Year |
|---|---|
Sulfonylureas and meglitinides: historical and contemporary issues.
Topics: Animals; Benzamides; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Glyburide; History, 20th Century; History, 21st Century; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Ischemic Preconditioning; Neoplasms; Risk Assessment; Risk Factors; Sulfonylurea Compounds; Treatment Outcome; Weight Gain | 2013 |
2 other study(ies) available for meglitinide and Neoplasms
| Article | Year |
|---|---|
Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus.
Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Neoplasms; Odds Ratio; Ohio; Proportional Hazards Models; Registries; Retrospective Studies; Risk; Sex Factors; Sulfonylurea Compounds; Thiazolidinediones | 2014 |
Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Breast Neoplasms; Cohort Studies; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Incidence; Male; Metformin; Middle Aged; Neoplasms; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; Thiazolidinediones; United Kingdom | 2013 |